Belanda - Belanda - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

fresenius medical care deutschland gmbh else-kröner-straße 1 61352 bad homburg v.d. h (duitsland) - calciumchloride 2-water (e 509) 183,8 mg/l samenstelling overeenkomend met ; calciumchloride 0-water (e 509) 138,8 mg/ml ; glucose 1-water 16,5 g/l samenstelling overeenkomend met ; glucose 0-water 15 g/l ; magnesiumchloride 6-water (e 511) 101,7 mg/l samenstelling overeenkomend met ; magnesiumchloride 0-water (e 511) 47,7 mg/l ; natriumchloride 5,786 g/l ; natriumlactaat (s-vorm) (e 325) 3,925 g/l ; samenstelling overeenkomend met calcium (ca2+) 1,25 mmol/l ; chloride (cl-) 102,5 mmol/l ; fructose (d-) 0,75 g/l ; glucose 0-water 83,2 mmol/l ; lactaat (s-vorm) (-) 35 mmol/l ; magnesium (mg2+) 0,5 mmol/l ; natrium (na+) 134 mmol/l - oplossing voor peritoneale dialyse - natriumhydroxide (e 524) ; water voor injectie ; zoutzuur (e 507), - isotonic solutions

Belanda - Belanda - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

fresenius medical care deutschland gmbh else-kröner-straße 1 61352 bad homburg v.d. h. (duitsland) - calciumchloride 2-water (e 509) 183,8 mg/l samenstelling overeenkomend met ; calciumchloride 0-water (e 509) 138,8 mg/l ; glucose 1-water 46,75 g/l samenstelling overeenkomend met ; glucose 0-water 42,5 g/l ; magnesiumchloride 6-water (e 511) 101,7 mg/l samenstelling overeenkomend met ; magnesiumchloride 0-water (e 511) 47,7 mg/l ; natriumchloride 5,786 g/l ; natriumlactaat (s-vorm) (e 325) 3,925 g/l ; samenstelling overeenkomend met calcium (ca2+) 1,25 mmol/l ; chloride (cl-) 102,5 mmol/l ; fructose (d-) 2,1 g/l ; glucose 0-water 235,8 mmol/l ; lactaat (s-vorm) (-) 35 mmol/l ; magnesium (mg2+) 0,5 mmol/l ; natrium (na+) 134 mmol/l - oplossing voor peritoneale dialyse - natriumhydroxide (e 524) ; water voor injectie ; zoutzuur (e 507), - hypertonic solutions

Belanda - Belanda - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

fresenius medical care deutschland gmbh else-kröner-straße 1 61352 bad homburg v.d. h (duitsland) - calciumchloride 2-water (e 509) 183,8 mg/l samenstelling overeenkomend met ; calciumchloride 0-water (e 509) 138,8 mg/l ; glucose 1-water 25 g/l samenstelling overeenkomend met ; glucose 0-water 22,73 g/l ; magnesiumchloride 6-water (e 511) 101,7 mg/l samenstelling overeenkomend met ; magnesiumchloride 0-water (e 511) 47,7 mg/l ; natriumchloride 5,786 g/l ; natriumlactaat (s-vorm) (e 325) 3,925 g/l ; samenstelling overeenkomend met calcium (ca2+) 1,25 mmol/l ; chloride (cl-) 102,5 mmol/l ; fructose (d-) 1,1 g/l ; glucose 0-water 126,1 mmol/l ; lactaat (s-vorm) (-) 35 mmol/l ; magnesium (mg2+) 0,5 mmol/l ; natrium (na+) 134 mmol/l - oplossing voor peritoneale dialyse - natriumhydroxide (e 524) ; water voor injectie ; zoutzuur (e 507), - isotonic solutions

Belanda - Belanda - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

ratiopharm gmbh - chloortalidon - tablet - aardappelzetmeel ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; povidon (e 1201) ; siliciumdioxide (e 551), - chlortalidone

Belanda - Belanda - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

ratiopharm gmbh - chloortalidon - tablet - aardappelzetmeel ; ijzeroxide geel (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; povidon (e 1201) ; siliciumdioxide (e 551), - chlortalidone

Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius medical care deutschland gmbh - natriumbicarbonaat 3,36 mg/ml; natriumchloride 5,5 mg/ml; calciumchloridedihydraat 0,18 mg/ml; glucosemonohydraat - eq. glucose 42,5 mg/ml; magnesiumchloridehexahydraat 0,1017 mg/ml - oplossing voor peritoneale dialyse - calciumchloridedihydraat 0.1 mg/ml; glucosemonohydraat; natriumbicarbonaat 3.36 mg/ml; magnesiumchloridehexahydraat 0.1017 mg/ml; natriumchloride 5.5 mg/ml - hypertonic solutions

Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

madaus gmbh - levonorgestrel 150 µg; ethinylestradiol 30 µg - omhulde tablet - 0,150 mg - 0,030 mg - levonorgestrel 150 µg; ethinylestradiol 30 µg - levonorgestrel and ethinylestradiol

Belanda - Belanda - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

aristo pharma gmbh wallenroder strasse 8-10 13435 berlijn (duitsland) - teriparatideacetaat hydraat samenstelling overeenkomend met ; ; teriparatide 250 µg/ml - oplossing voor injectie - azijnzuur (e 260), geconcentreerd ; mannitol (d-) (e 421) ; metacresol ; natriumacetaat 0-water (e 262) ; natriumhydroxide (e 524) ; water voor injectie ; zoutzuur (e 507)

Uni Eropa - Belanda - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccins - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. het gebruik van dit vaccin moet gebeuren in overeenstemming met officiële aanbevelingen.

Uni Eropa - Belanda - EMA (European Medicines Agency)

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccins - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.